Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways

Abstract Background: Non-canonical Wnt pathways play important roles in liver fibrosis. Notum is a newly discovered inhibitor to Wnt proteins. This study was to investigate anti-fibrotic effects of Notum. Methods: 53 patients with hepatitis B virus (HBV) infection as well as a cell co-culture syst...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li,Wenting, Yu,Xiaolan, Zhu,Chuanlong, Wang,Zheng, Zhao,Zonghao, Li,Yi, Zhang,Yonghong
Lenguaje:English
Publicado: Sociedad de Biología de Chile 2019
Materias:
HBV
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100208
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0716-97602019000100208
record_format dspace
spelling oai:scielo:S0716-976020190001002082019-10-10Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathwaysLi,WentingYu,XiaolanZhu,ChuanlongWang,ZhengZhao,ZonghaoLi,YiZhang,Yonghong Notum Wnt signaling pathway HBV Liver fibrosis Abstract Background: Non-canonical Wnt pathways play important roles in liver fibrosis. Notum is a newly discovered inhibitor to Wnt proteins. This study was to investigate anti-fibrotic effects of Notum. Methods: 53 patients with hepatitis B virus (HBV) infection as well as a cell co-culture system of LX-2 and Hep AD38 cells were engaged in this study. Clinical, biological and virological data of each patient were analyzed. Cell viability was detected at different time points. mRNA and protein levels of NFATc1 (Nuclear factor of activated T-cells), Jnk, &#945;-SMA, Col1A1 and TIMP-1 were detected both in LX-2 and liver tissue. Protein levels of NFATc1 and Jnk in liver tissue and their correlations with fibrosis score were analyzed. Results: Hepatitis B virus replication up-regulated Wnt5a induced NFATc1 and Jnk activity in Hep AD38. Notum suppressed NFATc1, Jnk and fibrosis genes expression, reduced cell viability in co-cultured LX-2 cells induced by HBV. Interestingly, Patients with HBV DNA > 5log copies/ml had higher mRNA levels of NFATc1 and fibrosis genes than patients with HBV DNA < 5log copies/ml. Most importantly, protein expressions of NFATc1 and pJnk have positive correlations with liver fibrosis scores in HBV-infected patients. Conclusions: Our data showed that Notum inhibited HBV-induced liver fibrosis through down-regulating Wnt 5a mediated non-canonical pathways. This study shed light on anti-fibrotic treatment.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.52 20192019-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100208en10.1186/s40659-019-0217-8
institution Scielo Chile
collection Scielo Chile
language English
topic Notum
Wnt signaling pathway
HBV
Liver fibrosis
spellingShingle Notum
Wnt signaling pathway
HBV
Liver fibrosis
Li,Wenting
Yu,Xiaolan
Zhu,Chuanlong
Wang,Zheng
Zhao,Zonghao
Li,Yi
Zhang,Yonghong
Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
description Abstract Background: Non-canonical Wnt pathways play important roles in liver fibrosis. Notum is a newly discovered inhibitor to Wnt proteins. This study was to investigate anti-fibrotic effects of Notum. Methods: 53 patients with hepatitis B virus (HBV) infection as well as a cell co-culture system of LX-2 and Hep AD38 cells were engaged in this study. Clinical, biological and virological data of each patient were analyzed. Cell viability was detected at different time points. mRNA and protein levels of NFATc1 (Nuclear factor of activated T-cells), Jnk, &#945;-SMA, Col1A1 and TIMP-1 were detected both in LX-2 and liver tissue. Protein levels of NFATc1 and Jnk in liver tissue and their correlations with fibrosis score were analyzed. Results: Hepatitis B virus replication up-regulated Wnt5a induced NFATc1 and Jnk activity in Hep AD38. Notum suppressed NFATc1, Jnk and fibrosis genes expression, reduced cell viability in co-cultured LX-2 cells induced by HBV. Interestingly, Patients with HBV DNA > 5log copies/ml had higher mRNA levels of NFATc1 and fibrosis genes than patients with HBV DNA < 5log copies/ml. Most importantly, protein expressions of NFATc1 and pJnk have positive correlations with liver fibrosis scores in HBV-infected patients. Conclusions: Our data showed that Notum inhibited HBV-induced liver fibrosis through down-regulating Wnt 5a mediated non-canonical pathways. This study shed light on anti-fibrotic treatment.
author Li,Wenting
Yu,Xiaolan
Zhu,Chuanlong
Wang,Zheng
Zhao,Zonghao
Li,Yi
Zhang,Yonghong
author_facet Li,Wenting
Yu,Xiaolan
Zhu,Chuanlong
Wang,Zheng
Zhao,Zonghao
Li,Yi
Zhang,Yonghong
author_sort Li,Wenting
title Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_short Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_full Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_fullStr Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_full_unstemmed Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_sort notum attenuates hbv-related liver fibrosis through inhibiting wnt 5a mediated non-canonical pathways
publisher Sociedad de Biología de Chile
publishDate 2019
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100208
work_keys_str_mv AT liwenting notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT yuxiaolan notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT zhuchuanlong notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT wangzheng notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT zhaozonghao notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT liyi notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT zhangyonghong notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
_version_ 1718441585431019520